Tirnovetmab Reference: HY-P99557 Tirnovetmab (KIND-016) is an antibody. Tirnovetmab can be used for experiment research.
Clenoliximab Reference: HY-P99607 Clenoliximab (IDEC-151) is a macaque-human chimeric monoclonal antibody (immunoglobulin G4) specific for the CD4 molecule on the surface of T lymphocytes. Clenoliximab can be used for the research of rheumatoid arthritis.
Navivumab Reference: HY-P99750 Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2.
SHR-1701 Reference: HY-P99944 SHR-1701 (Retlirafusp alfa) is a bifunctional fusion protein targeting PD-L1 and TGF-β for cancer research.
Canakinumab Reference: HY-108810 Canakinumab (ACZ885) is a recombinant human anti-IL-1β monoclonal antibody. Canakinumab shows IC50 values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin.
Lesofavumab Reference: HY-P99699 Lesofavumab (MHAB5553A) is a human IgG1κ anti-influenza B virus antibody.